Hepatitis B Virus X-Interacting Protein (HBXIP) (N-Term) Peptid
HBXIP
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle HBXIP Produkte
- HBXIP (Hepatitis B Virus X-Interacting Protein (HBXIP))
- Protein Region
- N-Term
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Sequenz
- FVPLEAPLRS TPRSRQVTEA CGGEGRAVPL GSEPEWSVGG MEATLEQHLE
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-HBXIP Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- HBXIP (Hepatitis B Virus X-Interacting Protein (HBXIP))
- Substanzklasse
- Viral Protein
- Hintergrund
-
HBXIP is a protein that specifically complexes with the C-terminus of hepatitis B virus X protein (HBx). The function of this protein is to negatively regulate HBx activity and thus to alter the replication life cycle of the virus.
Alias Symbols: MGC71071, XIP, HBXIP
Protein Interaction Partner: HBVgp3,EEF1A1,GAPDH,GIT1,GPRASP1,KIAA1377,LRIF1,MAF1,RABIF,UTP14A,ZBTB16,EEF1A1,GAPDH,GIT1,GPRASP1,KIAA1377,LRIF1,MAF1,NCOA6,RABIF,UTP14A,ZBTB16
Protein Size: 173 - Molekulargewicht
- 18 kDa
- Gen-ID
- 10542
- NCBI Accession
- NM_006402, NP_006393
-
Sie sind hier:
